Immix Biopharma Receives U.S. FDA Breakthrough Therapy Designation for NXC-201
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/9/2026
- S&P 500, Nasdaq end lower as crude prices jump, chip stocks weigh
- Oil rises 4% on revived Middle East worries, Hurricane Isaias supply disruption
- Chipotle, Starbucks shares volatile after report of potential takeover
- Why Citi says the Fed could be setting up for a dovish surprise
- Alphabet shares rise as Google pushes Gemini deeper into enterprise AI
| (NASDAQ: IMMX) | Delayed: 9.29 -0.2 (2.11%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $9.49 | 52 Week High | $ | |||
| Open | $9.37 | 52 Week Low | $ | |||
| Day High | $9.37 | P/E | N/A | |||
| Day Low | $8.96 | EPS | $ | |||
| Volume | 1,288,952 | |||||
